Results in Colchicine COVID-19 Trials Meta-Analysis are misleading

Published On 2021-11-27 05:22 GMT   |   Update On 2021-11-27 05:22 GMT

Colchicine use in COVID19 Trials Meta Analysis deem to be misleading A new meta-analysis appears to show that colchicine has no benefit as a treatment for COVID-19, but its inclusion of trials studying differing patient populations and testing different outcomes led to "misleading" results. The meta-analysis, which includes data from the recent Randomised Evaluation of COVID-19...

Login or Register to read the full article

Colchicine use in COVID19 Trials Meta Analysis deem to be misleading A new meta-analysis appears to show that colchicine has no benefit as a treatment for COVID-19, but its inclusion of trials studying differing patient populations and testing different outcomes led to "misleading" results. The meta-analysis, which includes data from the recent Randomised Evaluation of COVID-19 therapy (RECOVERY) trial, was published in RMD Open.


Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News